Laponis Adam 4
4 · Twist Bioscience Corp · Filed Jul 13, 2026
Research Summary
AI-generated summary of this filing
Twist Bioscience (TWST) CFO Adam Laponis Sells Shares
What Happened
- Adam Laponis, Chief Financial Officer of Twist Bioscience (TWST), sold 2,399 shares on July 9, 2026 at $94.33 per share, generating $226,307. The sale was a "sell-to-cover" tied to the vesting of restricted stock units (RSUs) and was used to satisfy tax-withholding obligations rather than a discretionary sale.
Key Details
- Transaction date: 2026-07-09; Price: $94.33 per share; Total proceeds: $226,307.
- Transaction type: Sale (S) — reported as open market or private sale but described in the footnote as a mandated sell-to-cover for taxes.
- Shares owned after transaction: Not disclosed in the filing excerpt.
- Filing: Report filed 2026-07-13 (covers period of report 2026-07-09); filing appears timely (filed within required business-day window).
- Footnote: Sale was required to cover tax withholding on vested RSUs and was not a discretionary trade by the reporting person.
Context
- Sell-to-cover transactions are common when RSUs vest: the company (or broker) sells a portion of the vested shares to pay required payroll/tax withholding. Such sales typically reflect tax mechanics, not an insider's view on the stock.
Insider Transaction Report
Form 4
Laponis Adam
Chief Financial Officer
Transactions
- Sale
Common Stock
[F1]2026-07-09$94.33/sh−2,399$226,307→ 110,276 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Adam Laponis|2026-07-13